NCT03965156

Brief Summary

  • Abdominal hysterectomy is an open surgical procedure associated with considerable post-operative pain. Narcotics are often required during patient recovery but can result in adverse side effects. Transversus abdominis plane block(TAP block) is a regional anesthetic technique that is found to be effective as post-operative analgesia after total abdominal hysterectomy. Recently, erector spinae plane block(ESP)block is found to be safe, and simple regional anesthetic technique that decrease total opioid consumption in patient undergoing breast, or abdominal surgery.
  • The aim is to compare the efficacy of bilateral erector spinae plane block, and bilateral transversus abdominis plane block on postoperative analgesia in patients after abdominal hysterectomy under general anesthesia, and their need for opioid. Hypothesis
  • Null hypothesis (H0): No difference between the analgesic effects of bilateral erector spinae plane block, and bilateral transversus abdominis plane block in patients after abdominal hysterectomy under general anesthesia.
  • Alternative hypothesis (H1): There are difference between the analgesic effects of bilateral erector spinae plane block, and bilateral transversus abdominis plane block in patients after abdominal hysterectomy under general anesthesia.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
48

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jun 2019

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 23, 2019

Completed
5 days until next milestone

First Posted

Study publicly available on registry

May 28, 2019

Completed
16 days until next milestone

Study Start

First participant enrolled

June 13, 2019

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2019

Completed
10 days until next milestone

Study Completion

Last participant's last visit for all outcomes

October 11, 2019

Completed
Last Updated

October 17, 2019

Status Verified

October 1, 2019

Enrollment Period

4 months

First QC Date

May 23, 2019

Last Update Submit

October 15, 2019

Conditions

Outcome Measures

Primary Outcomes (9)

  • The total amount of morphine given to each patient

    The total amount of morphine given to each patient during the first 24h of postoperative period

    the first 24 hours postoperative.

  • The time to first call to analgesia (morphine)

    morphine (rescue analgesic) will be given if VAS\>3.

    first call to morphine up to 24 hours postoperative.

  • Pain intensity using Visual analogue Scale (VAS) (McCormack et al., 1988).

    1- Pain intensity using Visual analogue Scale (VAS) (McCormack et al., 1988). A commonly used visual analog scale is a 10-cm line labeled with "worst pain imaginable" on the right border and "no pain" on the left border. The patient is instructed to make a mark along the line to represent the intensity of pain currently being experienced. VAS score will be assessed at 30 minutes, 2hs, 4hs, 6hs, 12hs, and 24hs postoperative and IV increment of 3mg morphine (rescue analgesic) will be given if VAS\>3.

    at 30 minutes postoperative.

  • Pain intensity using Visual analogue Scale (VAS)

    visual analogue scale is a 10-cm line labeled with "worst pain imaginable" on the right border and "no pain" on the left border.

    at 2 hours postoperative.

  • Pain intensity using Visual analogue Scale (VAS)

    visual analogue scale is a 10-cm line labeled with "worst pain imaginable" on the right border and "no pain" on the left border.

    at 4 hours postoperative.

  • Pain intensity using Visual analogue Scale (VAS)

    visual analogue scale is a 10-cm line labeled with "worst pain imaginable" on the right border and "no pain" on the left border.

    at 6 hours postoperative.

  • Pain intensity using Visual analogue Scale (VAS)

    visual analogue scale is a 10-cm line labeled with "worst pain imaginable" on the right border and "no pain" on the left border.

    at 12 hours postoperative.

  • Pain intensity using Visual analogue Scale (VAS)

    visual analogue scale is a 10-cm line labeled with "worst pain imaginable" on the right border and "no pain" on the left border.

    at 24 hours postoperative.

  • "Number of Participants with nausea, Vomiting, nausea or vomiting, hypotension, bradycardia, or any other complication"

    "Number of Participants with nausea, Vomiting, nausea or vomiting, hypotension, bradycardia, or any other complication"

    Up to 24 hours postoperative.

Secondary Outcomes (1)

  • Over all patient satisfaction

    all over 24 hours postoperative

Study Arms (2)

Erector Spinae Plane Block

ACTIVE COMPARATOR

Bilateral Ultrasound Guided Erector Spinae Plane Block

Procedure: 1) Ultrasound guided Erector spinae block

transversus abdominis plane block

ACTIVE COMPARATOR

Ultrasound guided transversus abdominis plane block

Procedure: Ultrasound guided transversus abdominis plane block

Interventions

In the lateral position, after skin sterilization, erector spinae plane block will be performed at the level of T9. Counting down from the spine of seventh cervical vertebrae, the spine of the nine thoracic vertebrae (T9). A linear low frequency ultrasound transducer (US) (3-5 MHz) will placed sagittal 3cm lateral to midline to visualize the muscles of the back, transverse process and simmering pleura in between transverse processes. A 22-gauge short bevel needle will be inserted in cranial-caudal direction towards transverse process (TP) in plane to the US transducer until needle touched the TP crossing all the muscles. The location of the needle tip will be confirmed by visible normal saline fluid separating erector spinae muscle off the bony shadow of the transverse process on ultrasound imaging. Then 20 ml of bupivacaine 0.375% plus plus 5ug/ml adrenaline (1:200000) will be injected. The procedure will be repeated following the same steps on the other side of the back.

Erector Spinae Plane Block

in supine position and after skin sterilization. The linear high frequency transducer (6-13 MHz) will be placed in the transverse plane to the the lateral abdominal wall in the midaxillary line, between the lower costal margin and iliac crest. The three abdominal wall muscles (external oblique, internal oblique, and transversus abdominis) are visualized. The needle inserted in plane and advanced anterior to posterior under continual visualization until the tip between the internal oblique and the transversus abdominis muscle. After negative aspiration, a 20 ml of bupivacaine 0.375% plus 5ug/ml adrenaline (1:200000) will be injected. The success of the injection will be confirmed by separation of the internal oblique and transversus abdominis with a distinct pocket of local anesthetic in between. The procedure will be repeated following the same steps on the other side.

transversus abdominis plane block

Eligibility Criteria

Age40 Years - 60 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Female Patient.
  • Patient acceptance.
  • Age (40-60) years old.
  • American Society of Anaesthesiologist (ASA) I / II
  • Elective total abdominal hysterectomy under general anesthesia.
  • patient With Body Mass Index (BMI) (25-35kg/m²)

You may not qualify if:

  • Patient refusal.
  • Local infection at site of puncture.
  • Altered mental status.
  • History of allergy to study drugs ( bupivacaine, morphine).
  • Patients with chronic pain.
  • Patients with severe hepatic or kidney impairment.
  • Patients having a history of hematological disorders, including coagulation abnormality.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Zagazig University Hospitsals

Zagazig, 055, Egypt

Location

Study Officials

  • Alshaimaa Kamel, M.D

    faculty of medicine ,zagazig universty

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER GOV
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
lecturer of Anaesthesia ,and surgical intensive care

Study Record Dates

First Submitted

May 23, 2019

First Posted

May 28, 2019

Study Start

June 13, 2019

Primary Completion

October 1, 2019

Study Completion

October 11, 2019

Last Updated

October 17, 2019

Record last verified: 2019-10

Data Sharing

IPD Sharing
Will not share

Locations